New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.97-0.48 (-1.10%)
At close: 04:00PM EST
42.31 -0.66 (-1.54%)
After hours: 07:49PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 58.67B
Enterprise value 66.18B
Trailing P/E 53.47
Forward P/E 22.27
PEG ratio (5-yr expected) 1.51
Price/sales (ttm)5.14
Price/book (mrq)3.56
Enterprise value/revenue 5.77
Enterprise value/EBITDA 24.46

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 316.83%
S&P500 52-week change 314.07%
52-week high 346.29
52-week low 335.05
50-day moving average 341.73
200-day moving average 342.93

Share statistics

Avg vol (3-month) 38.24M
Avg vol (10-day) 39.24M
Shares outstanding 51.42B
Implied shares outstanding 6N/A
Float 81.42B
% held by insiders 10.23%
% held by institutions 194.33%
Shares short (30 Dec 2021) 415.12M
Short ratio (30 Dec 2021) 41.87
Short % of float (30 Dec 2021) 41.06%
Short % of shares outstanding (30 Dec 2021) 41.06%
Shares short (prior month 29 Nov 2021) 414.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 305 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 10.08%
Operating margin (ttm)17.25%

Management effectiveness

Return on assets (ttm)3.94%
Return on equity (ttm)7.22%

Income statement

Revenue (ttm)11.47B
Revenue per share (ttm)8.06
Quarterly revenue growth (yoy)10.30%
Gross profit (ttm)6.79B
Net income avi to common (ttm)1.1B
Diluted EPS (ttm)0.77
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.95B
Total cash per share (mrq)1.37
Total debt (mrq)9.46B
Total debt/equity (mrq)57.48
Current ratio (mrq)1.55
Book value per share (mrq)11.55

Cash flow statement

Operating cash flow (ttm)2.06B
Levered free cash flow (ttm)2.26B